Apellis Pharmaceuticals, Inc. capitalization
Apellis Pharmaceuticals, Inc. capitalization musika ndeyesese yezvose Apellis Pharmaceuticals, Inc. mitengo yemitengo yakapihwa. Unogona kuwana iyo Apellis Pharmaceuticals, Inc. capitalization yanhasi zvichibva pakutengeserana kweyi stock quote pamusika wekutengesa stock. Apellis Pharmaceuticals, Inc. capitalization yanhasi pawebsite yedu yekureva. Apellis Pharmaceuticals, Inc., capitalization - 9 685 843 968 US madhora.
Apellis Pharmaceuticals, Inc. ivhu rekutengeserana
Apellis Pharmaceuticals, Inc. yekutengeserana yakawanda nhasi = 196 001 US madhora. Apellis Pharmaceuticals, Inc. yekutengesa vhoriyamu chati inoratidzwa pawebsite zuva nezuva. Apellis Pharmaceuticals, Inc. kutengeserana munguva chaiyo inobata pane dzakawanda kutengeserana quote exchanges, webhusaiti yedu inoratidza huwandu hwezuva nezuva hwekutengesa ye Apellis Pharmaceuticals, Inc.. Apellis Pharmaceuticals, Inc. capitalization yakawedzera ne $ 26 722 304.
|
Apellis Pharmaceuticals, Inc. musika wekodhi chati
Apellis Pharmaceuticals, Inc. capitalization yemusika pagirazi nemakore. -7.35% pasvondo - shanduko mumusika capitalization ye Apellis Pharmaceuticals, Inc.. Apellis Pharmaceuticals, Inc. shanduko yemari yegore i 0%. Apellis Pharmaceuticals, Inc. capitalization yakawedzera kana ichienzaniswa nezuro.
Vhiki | Mwedzi | 3 months | Gore | 3 years |
Apellis Pharmaceuticals, Inc. capital capital history
Zuva |
Capitalization
Capitalization (mutengo capital) ndiyo kukosha kwemusika wezvikamu zvose zvekambani zvakatengeswa pamutengo wekutengesa. Market capitalization yakaenzana nemutengo wezvikamu zvinowanikwa nenhamba yezvikamu zvakakosha.
|
---|---|
03/05/2023 | 9 685 843 968 $ |
02/05/2023 | 9 659 121 664 $ |
01/05/2023 | 9 617 297 408 $ |
28/04/2023 | 9 589 995 520 $ |
27/04/2023 | 9 656 217 600 $ |
26/04/2023 | 10 138 679 296 $ |
25/04/2023 | 10 454 354 944 $ |
Apellis Pharmaceuticals, Inc. vhidhiyo chati
Vhiki | Mwedzi | 3 months | Gore | 3 years |
Apellis Pharmaceuticals, Inc. nhoroondo yemota data
Zuva |
Bhuku (24h)
Nhamba yekutengeserana yeApellis Pharmaceuticals, Inc. zvikamu ndeyewandu hwezvinhu zvose zvekutengeserana neAPLS zvikamu zvakatengwa uye zvinotengeswa panguva yakasarudzwa.
|
---|---|
03/05/2023 | 196 001 $ |
02/05/2023 | 1 212 570 $ |
01/05/2023 | 1 460 879 $ |
28/04/2023 | 151 223 $ |
27/04/2023 | 1 985 743 $ |
26/04/2023 | 934 832 $ |
25/04/2023 | 1 350 399 $ |
Apellis Pharmaceuticals, Inc. capitalization yakakura kusvika 9 685 843 968 US madhora ku 03/05/2023. Apellis Pharmaceuticals, Inc. capitalization pa 02/05/2023 yakaenzana 9 659 121 664 US madhora. On 01/05/2023, Apellis Pharmaceuticals, Inc. misika yekutengesa yaive $ 9 617 297 408. 28/04/2023 Apellis Pharmaceuticals, Inc. capitalization yakasvika 9 589 995 520 US madhora.
Musika capitalization ye Apellis Pharmaceuticals, Inc. yakanzi 9 656 217 600 US madhora pa 27/04/2023. Apellis Pharmaceuticals, Inc. capitalization yakakura kusvika 10 138 679 296 US madhora ku 26/04/2023. Apellis Pharmaceuticals, Inc. capitalization pa 25/04/2023 yakaenzana 10 454 354 944 US madhora.
Iko mari yepamusoro yeApellis Pharmaceuticals, Inc. nhasi ndeye 9 685 843 968 $. Imari yepamusi yeApellis Pharmaceuticals, Inc. yakachinja +0.28% inofananidzwa nezuro. Nhamba yekutengeserana ye APLS nhengo dze Apellis Pharmaceuticals, Inc. musi wekupedzisira wekutengesa yakava 196 001 $. Kutengeswa kwezvikamu zve Apellis Pharmaceuticals, Inc. zvakachinjwa kusvika -83.836% zvichienzaniswa nezuva rekutanga rebhizimisi.